Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Accepts healthy volunteers

Essure Transvaginal Ultrasound (TVU) Study

ClinicalTrials.gov ID: NCT01327105

Public ClinicalTrials.gov record NCT01327105. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Use of Transvaginal Ultrasound to Confirm Essure® Micro-insert Placement in Women: Demonstration of Effectiveness

Study identification

NCT ID
NCT01327105
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Bayer
Industry
Enrollment
547 participants

Conditions and interventions

Interventions

  • TVU Device

Device

Eligibility (public fields only)

Age range
21 Years to 44 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 16, 2011
Primary completion
Jul 15, 2014
Completion
Jul 3, 2023
Last update posted
Aug 2, 2023

2011 – 2023

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
13
Facility City State ZIP Site status
Not listed Chandler Arizona 85224
Not listed Glendale Arizona 85306
Not listed Phoenix Arizona 85032
Not listed Tucson Arizona 85712
Not listed Arvada Colorado 80005
Not listed Fort Wayne Indiana 46825
Not listed Saginaw Michigan 48604
Not listed Rochester Minnesota 55905
Not listed The Bronx New York 10467
Not listed Asheville North Carolina 28801
Not listed Winston-Salem North Carolina 27103
Not listed Columbus Ohio 43231
Not listed Houston Texas 77074

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01327105, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2023 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01327105 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →